WO1997040151A3 - Secreted proteins and polynucleotides encoding them - Google Patents

Secreted proteins and polynucleotides encoding them Download PDF

Info

Publication number
WO1997040151A3
WO1997040151A3 PCT/US1997/006125 US9706125W WO9740151A3 WO 1997040151 A3 WO1997040151 A3 WO 1997040151A3 US 9706125 W US9706125 W US 9706125W WO 9740151 A3 WO9740151 A3 WO 9740151A3
Authority
WO
WIPO (PCT)
Prior art keywords
secreted proteins
polynucleotides encoding
cdna library
clones
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US1997/006125
Other languages
French (fr)
Other versions
WO1997040151A2 (en
Inventor
Kenneth Jacobs
John M Mccoy
Lisa A Racie
Edward R Lavallie
David Merberg
Vikki Spaulding
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genetics Institute LLC
Original Assignee
Genetics Institute LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genetics Institute LLC filed Critical Genetics Institute LLC
Priority to EP97921171A priority Critical patent/EP0954577A2/en
Priority to AU27286/97A priority patent/AU2728697A/en
Priority to JP9538135A priority patent/JP2000508908A/en
Publication of WO1997040151A2 publication Critical patent/WO1997040151A2/en
Publication of WO1997040151A3 publication Critical patent/WO1997040151A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

The invention provides 5 clones G 52-24, H 1075-1, J 59-41, H 83-22, J 143-1 isolated from a human PBMC cDNA library and one clone M 97-2 from a human glioblastoma cell line T 98 G cDNA library using a method of screening for cDNAs encoding secreted proteins. Determination of the nucleotide sequences and of the deduced amino acid sequences.
PCT/US1997/006125 1996-04-19 1997-04-14 Secreted proteins and polynucleotides encoding them Ceased WO1997040151A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP97921171A EP0954577A2 (en) 1996-04-19 1997-04-14 Secreted proteins and polynucleotides encoding them
AU27286/97A AU2728697A (en) 1996-04-19 1997-04-14 Secreted proteins and polynucleotides encoding them
JP9538135A JP2000508908A (en) 1996-04-19 1997-04-14 Secreted proteins and polynucleotides encoding them

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US63531196A 1996-04-19 1996-04-19
US08/635,311 1996-04-19
US78122697A 1997-01-10 1997-01-10
US08/781,226 1997-01-10

Publications (2)

Publication Number Publication Date
WO1997040151A2 WO1997040151A2 (en) 1997-10-30
WO1997040151A3 true WO1997040151A3 (en) 1998-02-05

Family

ID=27092348

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1997/006125 Ceased WO1997040151A2 (en) 1996-04-19 1997-04-14 Secreted proteins and polynucleotides encoding them

Country Status (5)

Country Link
EP (1) EP0954577A2 (en)
JP (1) JP2000508908A (en)
AU (1) AU2728697A (en)
CA (1) CA2251934A1 (en)
WO (1) WO1997040151A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8101349B2 (en) 1997-12-23 2012-01-24 Novartis Vaccines And Diagnostics, Inc. Gene products differentially expressed in cancerous cells and their methods of use II
MXPA01009491A (en) * 1999-03-25 2002-06-04 Squibb Bristol Myers Co Dna molecules encoding human clax proteins and their soluble fusion proteins.
EP1194549A2 (en) * 1999-07-02 2002-04-10 Chiron Corporation Human genes and gene expression products
US7939282B2 (en) * 2004-10-21 2011-05-10 Rhode Island Hospital Methods for detecting sepsis
US7842467B1 (en) 2005-05-12 2010-11-30 Celera Corporation Breast disease targets and uses thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5536637A (en) * 1993-04-07 1996-07-16 Genetics Institute, Inc. Method of screening for cDNA encoding novel secreted mammalian proteins in yeast

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5536637A (en) * 1993-04-07 1996-07-16 Genetics Institute, Inc. Method of screening for cDNA encoding novel secreted mammalian proteins in yeast

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
ENG MONG LIM ET AL: "IDENTIFICATION OF MYCOBACTERIUM TUBERCULOSIS DNA SEQUENCES ENCODING EXPORTED PROTEINS BY USING PHOA GENE FUSIONS", JOURNAL OF BACTERIOLOGY, vol. 177, no. 1, 1 January 1995 (1995-01-01), pages 59 - 65, XP000560419 *
HILLIER H . EET AL: "The WashU-Merck EST project : za49a11.s1 homo sapiens cDNA clone 295868 .", EMBL DATABASE ENTRY HS 007301 .ACCESSION NUMBER N67007( VERSION 2), 9 April 1996 (1996-04-09), XP002039159 *
K. JACOBS ET AL: "A novel method for isolating eukaryotic cDNA clones encoding secreted proteins", JOURNAL OF CELLULAR BIOCHEMISTRY, vol. 21A, no. suppl0, 10 March 1995 (1995-03-10) - 4 April 1995 (1995-04-04), pages 19, XP002027246 *
L. HILLIER ET AL: "The WashU-Merck EST project", EMBL DATABASE ENTRY . HSA29932 . ACESSION NUMBER : AA029932, 20 August 1996 (1996-08-20), XP002039170 *
L. HILLIER ET AL: "The WashU-Merck EST project", EMBL DATABASE ENTRY HSA28937 . ACCESSION NUMBER : AA028937, 20 August 1996 (1996-08-20), XP002039158 *
L.HILLIER ET AL: "The WashU-Merck EST project .", EMBL DATABASE ENTRY HS 30080, ACCESSION NUMBER R12300(VERSION 1), 21 April 1995 (1995-04-21), XP002039157 *
R.E. CALLARD , A. J.H. GEARING: "the cytokine factsbook", 1994, ACADEMIC PRESS HARCOURT BRACE & COMPANY, PUBLISHERS, LONDON, XP002039160, 209420 *

Also Published As

Publication number Publication date
WO1997040151A2 (en) 1997-10-30
CA2251934A1 (en) 1997-10-30
EP0954577A2 (en) 1999-11-10
AU2728697A (en) 1997-11-12
JP2000508908A (en) 2000-07-18

Similar Documents

Publication Publication Date Title
WO2001088092A3 (en) Methods and materials relating to stem cell factor-like (scf-like) polypeptides and polynucleotides
WO2000061765A3 (en) Lipoxygenase proteins and polynucleotides encoding the same
IL205233A0 (en) A polypeptide comprising the amino acid sequence of osteoprotegerin from residues 22 to 401 inclusive, or a fragment or trunaction thereof
WO2000005366A3 (en) Xiap ires and uses thereof
EP1440981A3 (en) Full-length human cdna
WO2001077169A3 (en) Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides
WO2001055336A3 (en) Methods and materials relating to cd84-like polypeptides and polynucleotides
CA2343715A1 (en) New human growth differentiation factor encoding sequence and polypeptide encoded by such dna sequence and producing method thereof
WO2001053454A3 (en) Methods and materials relating to g protein-coupled receptor-like polypeptides and polynucleotides
WO1991009121A3 (en) Polypeptides having thyrotropin-receptor activity, nucleic acid sequences coding for such receptors and polypeptides, and applications of these polypeptides
WO2004031362A3 (en) Multimeric protein engineering
WO1997040151A3 (en) Secreted proteins and polynucleotides encoding them
EP0255011A3 (en) Human inter-alpha-trypsin inhibitor gene
ZA9810060B (en) Process for the hydrogenation of diene (co)polymers
WO1997040069A3 (en) Secreted proteins and polynucleotides encoding them
WO2003070751A3 (en) Partial peptide mimetics and methods
WO2003029405A3 (en) Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides
WO1997046682A3 (en) Polynucleotides from human adult PBMC encoding secreted proteins
WO2001055335A3 (en) Methods and materials relating to leukocyte immunoglobulin receptor-like (lir-like) polypeptides and polynucleotides
EP1574520A3 (en) Methods and materials relating to neuronal guidance molecule-like (NGM-like) polypeptides and polynucleotides
WO1997038084A3 (en) Polynucleotides derived from a pbmc cdna library encoding secreted proteins
IL126512A0 (en) Alpha2 subunit of prolyl-4-hydroxylase nucleic acid sequences encoding such subunit and methods for producing the same
WO2001053500A8 (en) Methods and materials relating to stem cell growth factor-like poypeptides and polynucleotides
WO1997048801A3 (en) Polynucleotides encoding secreted proteins
WO2001075064A3 (en) Method and materials relating to insulin-like growth factor binding protein-like polypeptides and polynucleotides

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU CA JP MX

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
ENP Entry into the national phase

Ref document number: 2251934

Country of ref document: CA

Ref country code: CA

Ref document number: 2251934

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 1997921171

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1997921171

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1997921171

Country of ref document: EP